Suppr超能文献

[β受体阻滞剂长期口服治疗对体外循环后冠心病患者使用肾上腺素进行正性肌力治疗是否有影响?]

[Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].

作者信息

Günnicker M, Brinkmann M, Freund U, Piotrowski J, Schieffer M, Velser U

机构信息

Institut für Anästhesiologie, Universitätsklinikum der Gesamthochschule Essen.

出版信息

Herz. 1995 Dec;20(6):399-411.

PMID:8582699
Abstract

UNLABELLED

For the prebypass period various authors have shown that patients on oral or intravenous beta blocking therapy respond to catecholamine treatment with marked increase in afterload and no change in cardiac index. Since positive inotropic therapy is usually not necessary until, but after termination of cardiopulmonary bypass, the question arises as to whether beta-blocking agents administered orally on the morning of the operation, can still have negative effects during this phase of the procedure.

PATIENTS AND METHODS

20 patients (NYHA classification II to III) undergoing coronary artery bypass grafting, half of them having been on chronic beta-adrenoceptor blocking therapy, were treated with 0.1 micrograms/kg/min adrenaline as an infusion, when following cardiopulmonary bypass cardiac index was < 2.4 l/min/m2 with left and/or right ventricular filling pressures being normal or raised. Haemodynamic monitoring consisted of ECG, direct arterial pressure, a pulmonary artery catheter and of an additional thermodilution catheter placed directly into the coronary sinus. The parameters looked at were mean arterial pressure (MAP), heart rate (HR), cardiac index (CI), coronary perfusion pressure (CPP), total peripheral resistance (TPR), pulmonary capillary wedge pressure (PCWP), right atrial pressure (RAP), pressure work index (PWI), myocardial blood flow (MBF) and myocardial oxygen consumption (MVO2). Arterial and myocardial lactate levels were measured and from that myocardial lactate extraction and production were calculated. Measurements were made immediately following termination of cardiopulmonary bypass and then after 15, 30, 45 and 60 minutes under continuous infusion of adrenaline. In addition left ventricular pressure was measured via transseptal needle for calculation of myocardial contractility dp/dtmax directly after termination of cardiopulmonary bypass and 15 minutes later with adrenaline therapy. Prior to induction of anaesthesia and following termination of cardiopulmonary bypass blood samples were taken to measure plasma levels of the beta blocking drug.

RESULTS

All 10 patients on oral beta blocking therapy had plasma levels within the therapeutic range prior to induction of anaesthesia. Following cardiopulmonary bypass the plasma levels had fallen by 50% on average, but with 2 exceptions, they were still within the therapeutic range (Table 2). Irrespective of the fact whether preoperatively beta blockers had been taken, adrenaline caused a significant increase in contractility (Table 3), mean arterial pressure (Figure 1), heart rate (Table 3) and cardiac index (Figure 2). There was a comparable increase of pressure work index (Figure 5), myocardial blood flow (Figure 6) and myocardial oxygen consumption (Figure 7) in both groups. Effect on afterload was significantly different. In both groups MAP was increased but that was more marked in the presence of beta blockade (Figure 1). Total peripheral resistance fell in the group without preoperative beta blockade whereas in patients on preoperative beta blockade TPR increased by 100 dyn.s.cm-5 on average (Figure 4). As a consequence adrenaline infusion caused an increase in CPP only in the presence of beta blockade (Figure 3). In both groups adrenaline infusion caused an increase in arterial and myocardial lactate levels (Tables 6 and 7). Some patients without preoperative beta blockade showed myocardial lactate production whereas in the presence of beta blockade myocardial lactate extraction was found at all points of measurement (Figure 8).

CONCLUSION

Our results show, that observations made by various groups in the prebypass period on patients treated with beta blocking agents, which demonstrate dramatic increases in afterload with no improvement in cardiac index following catecholamine administration do not hold true for the post-bypass period. The reason could be a wash out effect of the Bretschneider cardioplegia on cardiac beta receptors.

摘要

未标记

对于体外循环前阶段,不同作者已表明,接受口服或静脉β受体阻滞剂治疗的患者对儿茶酚胺治疗的反应是后负荷显著增加而心脏指数无变化。由于通常在体外循环结束后而非之前才需要使用正性肌力治疗,因此出现了一个问题,即手术当天早晨口服的β受体阻滞剂在此阶段是否仍会产生负面影响。

患者与方法

20例(纽约心脏协会心功能分级II至III级)接受冠状动脉搭桥术的患者,其中一半接受慢性β肾上腺素能受体阻滞剂治疗,在体外循环后心脏指数<2.4升/分钟/平方米且左和/或右心室充盈压正常或升高时,以0.1微克/千克/分钟的速度静脉输注肾上腺素进行治疗。血流动力学监测包括心电图、直接动脉压、肺动脉导管以及直接置于冠状窦的额外热稀释导管。观察的参数有平均动脉压(MAP)、心率(HR)、心脏指数(CI)、冠状动脉灌注压(CPP)、总外周阻力(TPR)、肺毛细血管楔压(PCWP)、右心房压(RAP)、压力作功指数(PWI)、心肌血流量(MBF)和心肌氧耗量(MVO2)。测量动脉和心肌乳酸水平,并据此计算心肌乳酸摄取和生成量。在体外循环结束后立即进行测量,然后在持续输注肾上腺素的情况下于15、30、45和60分钟后再次测量。此外,在体外循环结束后及肾上腺素治疗15分钟后,通过经间隔穿刺针测量左心室压力以直接计算心肌收缩力dp/dtmax。在麻醉诱导前及体外循环结束后采集血样以测量β受体阻滞剂的血浆水平。

结果

所有10例接受口服β受体阻滞剂治疗的患者在麻醉诱导前血浆水平均在治疗范围内。体外循环后血浆水平平均下降了50%,但有2例例外,仍在治疗范围内(表2)。无论术前是否服用β受体阻滞剂,肾上腺素均导致收缩力(表3)、平均动脉压(图1)、心率(表3)和心脏指数(图2)显著增加。两组的压力作功指数(图5)、心肌血流量(图6)和心肌氧耗量(图7)均有类似增加。对后负荷的影响显著不同。两组的MAP均升高,但在存在β受体阻滞剂时更为明显(图1)。术前未使用β受体阻滞剂的组总外周阻力下降而术前使用β受体阻滞剂的患者TPR平均增加100达因·秒/厘米⁻⁵(图4)。因此,肾上腺素输注仅在存在β受体阻滞剂时导致CPP增加(图3)。两组中肾上腺素输注均导致动脉和心肌乳酸水平升高(表6和表7)。一些术前未使用β受体阻滞剂的患者出现心肌乳酸生成,而在存在β受体阻滞剂时在所有测量点均发现心肌乳酸摄取(图8)。

结论

我们的结果表明,不同研究组在体外循环前阶段对接受β受体阻滞剂治疗患者的观察结果,即儿茶酚胺给药后后负荷显著增加而心脏指数无改善,在体外循环后阶段并不成立。原因可能是布雷施奈德心脏停搏液对心脏β受体的洗脱作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验